301-400

301. Carpentier A, Deloche A, Dauptain J, et al. A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg
1971; 61: 1-13.
302. Duran CG, Ubago JL. Clinical and hemodynamic performance of a totally flexible prosthetic ring for atrioventricular valve reconstruction. Ann Thorac
Surg 1976; 22: 458-463.
303. McCarthy JF, Cosgrove DM, III. Tricuspid valve repair with the Cosgrove-Edwards Annuloplasty System. Ann Thorac Surg 1997; 64: 267-268.
304. Yada I, Tani K, Shimono T, et al. Preoperative evaluation and surgical treatment for tricuspid regurgitation associated with acquired valvular heart
disease. The Kay-Boyd method vs the Carpentier-Edwards ring method. J Cardiovasc Surg (Torino) 1990; 31: 771-777.
305. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004; 127: 674
-685.
306. Tang GH, David TE, Singh SK, et al. Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation 2006; 114
(1 Suppl): I577-I581.
307. Onoda K, Yasuda F, Takao M, et al. Long-term follow-up after Carpentier-Edwards ring annuloplasty for tricuspid regurgitation. Ann Thorac Surg 2000;
70: 796-799.
308. 岡田昌義　監修．心臓血管外科の最前線．先端医療技術研究所，東京 1999: 53-61.
309. Abe T, Tukamoto M, Yanagiya M, et al. De Vega’s annuloplasty for acquired tricuspid disease: early and late results in 110 patients. Ann Thorac
Surg 1989; 48: 670-676.
310. Nakano S, Kawashima Y, Hirose H, et al. Evaluation of long-term results of bicuspidalization annuloplasty for functional tricuspid regurgitation. A
seventeen-year experience with 133 consecutive patients. J Thorac Cardiovasc Surg 1988; 95: 340-345.
311. Nakano K, Ishibashi-Ueda H, Kobayashi J, et al. Tricuspid valve replacement with bioprostheses: long-term results and causes of valve dysfunction.
Ann Thorac Surg 2001; 71: 105-109.
312. Tokunaga S, Masuda M, Shiose A, et al. Long-term results of isolated tricuspid valve replacement. Asian Cardiovasc Thorac Ann 2008; 16: 25-28.
313. Kawano H, Oda T, Fukunaga S, et al. Tricuspid valve replacement with the St. Jude Medical valve: 19 years of experience. Eur J Cardiothorac Surg
2000; 18: 565-569.
314. Rizzoli G, Vendramin I, Nesseris G, et al. Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional results. Ann
Thorac Surg 2004; 77: 1607-1614.
315. Schattenberg TT, Titus JL, Parkin TW. Clinical findings in acquired aortic valve stenosis: effect of disease of other valves. Am Heart J 1967; 73:
322-325.
316. Gash AK, Carabello BA, Kent RL, et al. Left ventricular performance in patients with coexistent mitral stenosis and aortic insufficiency. J Am Coll
Cardiol 1984; 3: 703-711.
317. Weissman NJ, Pini R, Roman MJ, et al. In vivo mitral valve morphology and motion in mitral valve prolapse. Am J Cardiol 1994; 73: 1080-1088.
318. Zitnik RS, Piemme TE, Messer RJ, et al. The masking of aortic stenosis by mitral stenosis. Am Heart J 1965; 69: 22-30.
319. Matsumura M, Wong M, Omoto R. Assessment of Doppler color flow mapping in quantification of aortic regurgitationcorrelations and influencing
factors. Jpn Circ J 1989; 53: 735-746.
320. Fawzy ME, Choi WB, Mimish L, et al. Immediate and long-term effect of mitral balloon valvotomy on left ventricular volume and systolic function in
severe mitral stenosis. Am Heart J 1996; 132(2 Pt 1): 356-360.
321. Macmanus Q, Grunkemeier G, Starr A. Late results of triple valve replacement: a 14-year review. Ann Thorac Surg 1978; 25: 402-406.
322. Skudicky D, Essop MR, Sareli P. Efficacy of mitral balloon valvotomy in reducing the severity of associated tricuspid valve regurgitation. Am J Cardiol
1994; 73: 209-211.
323. Spencer FC, Colvin SB, Culliford AT, et al. Experiences with the Carpentier techniques of mitral valve reconstruction in 103 patients (1980-1985).
J Thorac Cardiovasc Surg 1985; 90: 341-350.
324. Gillinov AM, Blackstone EH, Cosgrove DM, III, et al. Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac
Cardiovasc Surg 2003; 125: 1372-1387.
325. John S, Ravikumar E, John CN, et al. 25-year experience with 456 combined mitral and aortic valve replacement for rheumatic heart disease. Ann
Thorac Surg 2000; 69: 1167-1172.
326. Teoh KH, Christakis GT, Weisel RD, et al. The determinants of mortality and morbidity after multiple-valve operations. Ann Thorac Surg 1987; 43: 353
-358.
327. Bortolotti U, Milano A, Testolin L, et al. Influence of type of prosthesis on late results after combined mitral-aortic valve replacement. Ann Thorac Surg
1991; 52: 84-91.
328. Brown PS, Jr., Roberts CS, McIntosh CL, et al. Relation between choice of prostheses and late outcome in doublevalve replacement. Ann Thorac Surg
1993; 55: 631-640.
329. Nitter-Hauge S, Horstkotte D. Management of multivalvular heart disease. Eur Heart J 1987; 8: 643-646.
330. Galloway AC, Grossi EA, Baumann FG, et al. Multiple valve operation for advanced valvular heart disease: results and risk factors in 513 patients. J
Am Coll Cardiol 1992; 19: 725-732.
331. Armenti F, Stephenson LW, Edmunds LH, Jr. Simultaneous implantation of St. Jude Medical aortic and mitral prostheses. J Thorac Cardiovasc Surg
1987; 94: 733-739.
332. Arom KV, Nicoloff DM, Kersten TE, et al. Ten-year follow-up study of patients who had double valve replacement with the St. Jude Medical prosthesis.
J Thorac Cardiovasc Surg 1989; 98(5 Pt 2): 1008-1015.
333. Baudet EM, Puel V, McBride JT, et al. Long-term results of valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1995;
109: 858-870.
334. Borman JB, Brands WG, Camilleri L, et al. Bicarbon valve -- European multicenter clinical evaluation. Eur J Cardiothorac Surg 1998; 13: 685-693.
335. Burckhardt D, Striebel D, Vogt S, et al. Heart valve replacement with St. Jude Medical valve prosthesis. Longterm experience in 743 patients in
Switzerland. Circulation 1988; 78(3 Pt 2): I18-I24.
336. Butchart EG, Li HH, Payne N, et al . Twenty years’experience with the Medtronic Hall valve. J Thorac Cardiovasc Surg 2001; 121: 1090-1100.
337. Copeland JG, III. An international experience with the CarboMedics prosthetic heart valve. J Heart Valve Dis 1995; 4: 56-62.
338. Czer LS, Chaux A, Matloff JM, et al. Ten-year experience with the St. Jude Medical valve for primary valve replacement. J Thorac Cardiovasc Surg
1990; 100: 44-54.
339. de LL, Vitale N, Giannolo B, et al. Mid-term follow-up after heart valve replacement with CarboMedics bileaflet prostheses. J Thorac Cardiovasc Surg
1993; 106: 1158-1165.
340. Ibrahim M, O’Kane H, Cleland J, et al. The St. Jude Medical prosthesis. A thirteen-year experience. J Thorac Cardiovasc Surg 1994; 108: 221-230.
341. Kinsley RH, Antunes MJ, Colsen PR. St. Jude Medical valve replacement. An evaluation of valve performance. J Thorac Cardiovasc Surg 1986; 92
(3 Pt 1): 349-360.
342. Smith JA, Westlake GW, Mullerworth MH, et al. Excellent long-term results of cardiac valve replacement with the St Jude Medical valve prosthesis.
Circulation 1993; 88(5 Pt 2): II49-II54.
343. John S, Ravikumar E, Jairaj PS, et al. Valve replacement in the young patient with rheumatic heart disease. Review of a twenty-year experience.
J Thorac Cardiovasc Surg 1990; 99: 631-638.
344. John S, John C, Saha K, et al. A quarter century experience with mitral valve replacement. Asian Cardiovasc Thorac Ann 1996; 4: 201-205.
345. Yasui H, Osada H, Ando M, et al. Thoracic and Cardiovascular surgery in Japan during 1996: annural report by the Japanese association for thoracic
surgery. Jpn J Thoracic Cardiovasc Surg 1998; 45: 407-413.
346. Yasuda K, Ayabe H, Ide H, et al. Committee of Science. Japanese Association for Thoracic Surgery: Thoracic and Cardiovascular Surgery in Japan
during 1999. Annual report by the Japanese Association for Thoracic Surgery. Jpn J Thorac Cardiovasc Surg 2001; 49: 528-541.
347. Fremes SE, Goldman BS, Ivanov J, et al. Valvular surgery in the elderly. Circulation 1989; 80(3 Pt 1): I77-I90.
348. Verheul HA, van den Brink RB, Bouma BJ, et al. Analysis of risk factors for excess mortality after aortic valve replacement. J Am Coll Cardiol 1995;
26: 1280-1286.
349. Czer LS, Gray RJ, Stewart ME, et al. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. J Thorac
Cardiovasc Surg 1988; 95: 390-401.
350. Iung B, Drissi MF, Michel PL, et al. Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative
study. J Heart Valve Dis 1993; 2: 430-439.
351. Lund O, Nielsen TT, Pilegaard HK, et al. The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement
for aortic stenosis. J Thorac Cardiovasc Surg 1990; 100: 327-337.
352. Mullany CJ, Elveback LR, Frye RL, et al. Coronary artery disease and its management: influence on survival in patients undergoing aortic valve
replacement. J Am Coll Cardiol 1987; 10: 66-72.
353. Hwang MH, Hammermeister KE, Oprian C, et al. Preoperative identification of patients likely to have left ventricular dysfunction after aortic valve
replacement. Participants in the Veterans Administration Cooperative Study on Valvular Heart Disease. Circulation 1989; 80(3 Pt 1): I65-I76.
354. Otto CM, Pearlman AS, Amsler LC. Doppler echocardiographic evaluation of left ventricular diastolic filling in isolated valvular aortic stenosis. Am
J Cardiol 1989; 63: 313-316.
355. Braverman AC, Guven H, Beardslee MA, et al. The bicuspid aortic valve. Curr Probl Cardiol 2005; 30: 470-522.
356. Nataatmadja M, West M, West J, et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth
muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 2003; 108, Suppl 1: II329-II334.
357. Ferencik M, Pape LA. Changes in size of ascending aorta and aortic valve function with time in patients with congenitally bicuspid aortic valves. Am
J Cardiol 2003; 92: 43-46.
358. McKellar SH, Michelena HI, Li Z, et al. Long-term risk of aortic events following aortic valve replacement in patients with bicuspid aortic valves. Am J
Cardiol 2010; 106: 1626-1633.
359. Michelena HI, Khanna AD, Mahoney D, et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 2011; 306: 1104-1112.
360. Thanassoulis G, Yip JW, Filion K, et al. Retrospective study to identify predictors of the presence and rapid progression of aortic dilatation in patients
with bicuspid aortic valves. Nat Clin Pract Cardiovasc Med 2008; 5: 821-828.
361. Davies RR, Goldstein LJ, Coady MA, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann
Thorac Surg 2002; 73: 17-27.
362. Kallenbach K, Hagl C, Walles T, et al. Results of valvesparing aortic root reconstruction in 158 consecutive patients. Ann Thorac Surg 2002; 74:
2026-2032.
363. Zehr KJ, Orszulak TA, Mullany CJ, et al. Surgery for aneurysms of the aortic root: a 30-year experience. Circulation 2004; 110: 1364-1371.
364. Tanaka H, Ogino H, Matsuda H, et al. Midterm outcome of valve-sparing aortic root replacement in inherited connective tissue disorders. Ann Thorac
Surg 2011; 92: 1646-1649.
365. Coady MA, Rizzo JA, Hammond GL, et al. What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg
1997; 113: 476-491.
366. Prenger K, Pieters F, Cheriex E. Aortic dissection after aortic valve replacement: incidence and consequences for strategy. J Card Surg 1994; 9:
495-498.
367. Booher AM, Eagle KA. Diagnosis and management issues in thoracic aortic aneurysm. Am Heart J 2011; 162: 38-46.
368. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI /SIR/STS/SVM guidelines for the diagnosis and
management of patients with thoracic aortic disease: executive summary. A report of the American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke
Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology,
Society of Thoracic Surgeons, and Society for Vascular Medicine. Catheter Cardiovasc Interv 2010; 76: E43-E86.
369. Botzenhardt F, Hoffmann E, Kemkes BM, et al. Determinants of ascending aortic dimensions after aortic valve replacement with a stented
bioprosthesis. J Heart Valve Dis 2007; 16: 19-26.
370. Matsuyama K, Usui A, Akita T, et al. Natural history of a dilated ascending aorta after aortic valve replacement. Circ J 2005; 69: 392-396.
371. Dapunt OE, Galla JD, Sadeghi AM, et al. The natural history of thoracic aortic aneurysms. J Thorac Cardiovasc Surg 1994; 107: 1323-1332.
372. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the
American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the
Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the
Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-231.
373. Tadros TM, Klein MD, Shapira OM. Ascending aortic dilatation associated with bicuspid aorticvalve : pathophysiology, molecular biology, and clinical
implications. Circulation 2009; 119: 880-890.
374. Davies RR, Gallo A, Coady MA, et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 2006;
81: 169-177.
375. Svensson LG, Khitin L. Aortic cross-sectional area/height ratio timing of aortic surgery in asymptomatic patients with Marfan syndrome. J Thorac
Cardiovasc Surg 2002; 123: 360-361.
376. Svensson LG, Kim KH, Lytle BW, et al. Relationship of aortic cross-sectional area to height ratio and the risk of aortic dissection in patients with
bicuspid aortic valves. J Thorac Cardiovasc Surg 2003; 126: 892-893.
377. Eishi K, Kawazoe K, Kuriyama Y, et al. Surgical management of infective endocarditis associated with cerebral complications. Multi-center
retrospective study in Japan. J Thorac Cardiovasc Surg 1995; 110: 1745-1755.
378. Piper C, Wiemer M, Schulte HD, et al. Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis
2001; 10: 703-711.
379. Ruttmann E, Willeit J, Ulmer H, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006; 37: 2094-2099.
380. Paciaroni M, Agnelli G, Corea F, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome:
results of a prospective multicenter study. Stroke 2008; 39: 2249-2256.
381. Hart RG, Kagan-Hallet K, Joerns SE. Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke 1987; 18: 1048-1056.
382. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations :
A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991
guidelines for coronary artery bypass graft surgery). Circulation 1999; 100: 1464-1480.
383. North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke 1991; 22: 711-720.
384. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid
Endarterectomy Trial Collaborators. N Engl J Med 1991; 325: 445-453.
385. Coward LJ, Featherstone RL, Brown MM. Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid
endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke 2005; 36: 905-911.
386. Gurm HS, Yadav JS, Fayad P, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 2008; 358:
1572-1579.
387. Ringleb PA, Allenberg J, Bruckmann H, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in
symptomatic patients: a randomised non-inferiority trial. Lancet 2006; 368: 1239-1247.
388. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;
273: 1421-1428.
389. Ghosh J, Murray D, Khwaja N, et al. The influence of asymptomatic significant carotid disease on mortality and morbidity in patients undergoing
coronary artery bypass surgery. Eur J Vasc Endovasc Surg 2005; 29: 88-90.
390. Murphy MO, Ghosh J, Omorphos S, et al. In patients undergoing cardiac surgery does asymptomatic significant carotid artery stenosis warrant
carotid endarterectomy? Interact Cardiovasc Thorac Surg 2005; 4: 344-349.
391. Paciaroni M, Caso V, Acciarresi M, et al. Management of asymptomatic carotid stenosis in patients undergoing general and vascular surgical
procedures. J Neurol Neurosurg Psychiatry 2005; 76: 1332-1336.
392. Illuminati G, Ricco JB, Calio F, et al. Short-term results of a randomized trial examining timing of carotid endarterectomy in patients with severe
asymptomatic unilateral carotid stenosis undergoing coronary artery bypass grafting. J Vasc Surg 2011; 54: 993-999.
393. Rizzo RJ, Whittemore AD, Couper GS, et al. Combined carotid and coronary revascularization: the preferred approach to the severe vasculopath. Ann
Thorac Surg 1992; 54: 1099-1108.
394. Vermeulen FE, Hamerlijnck RP, Defauw JJ, et al. Synchronous operation for ischemic cardiac and cerebrovascular disease: early results and long
-term followup. Ann Thorac Surg 1992; 53: 381-389.
395. Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth
Analg 2007; 104: 51-58.
396. Hashimoto K, Onoguchi K, Takakura H, et al. Beneficial effect of balloon-induced pulsatility on brain oxygenation in hypothermic cardiopulmonary
bypass. J Cardiovasc Surg (Torino) 2001; 42: 587-593.
397. Hong SW, Shim JK, Choi YS, et al. Prediction of cognitive dysfunction and patients’ outcome following valvular heart surgery and the role of cerebral
oximetry. Eur J Cardiothorac Surg 2008; 33: 560-565.
398. White PM, Wardlaw JM, Easton V. Can noninvasive imaging accurately depict intracranial aneurysms? A systematic review. Radiology 2000; 217:
361-370.
399. Wiebers DO, Whisnant JP, Huston J, III, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and
endovascular treatment. Lancet 2003; 362: 103-110.
400. Wermer MJ, van der Schaaf IC, Algra A, et al. Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics:
an updated metaanalysis. Stroke 2007; 38: 1404-1410.

文献